Eisai Shrinks India Multiple Sclerosis Commercial Team
Executive Summary
Eisai recalibrates sales and marketing efforts for Biogen’s multiple sclerosis portfolio in India, joining a growing list of foreign firms that appear to be rightsizing their commercial engine in an ultra-competitive market.